Hydrogel formulation of phosphosulindac allows once-a-day ocular dosing and limits its biodistribution to the anterior chamber: Application to dry eye disease treatment-Reference-Cited by-同舟云学术

Hydrogel formulation of phosphosulindac allows once-a-day ocular dosing and limits its biodistribution to the anterior chamber: Application to dry eye disease treatment

Published:2022-01 Issue: Volume:67 Page:102961
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Huang Wei,Huang Liqun,Tsioulias Anna^ORCID,Wen Ziyi,Saglam Sait,Goldstein Sanford M.,Honkanen Robert,Rigas Basil^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference19 articles.

1. Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats;Mattheolabakis;Pharmaceutic. Res.,2013

2. Phosphosulindac is efficacious in an improved concanavalin A-based rabbit model of chronic dry eye disease;Honkanen;Transl Res,2018

3. The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: enhanced and targeted tissue drug delivery;Wen;Int. J. Pharmaceutic.,2019

4. Dosing frequency and medication adherence in chronic disease;Coleman;J. Managed Care Pharmacy.: JMCP,2012

5. Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers;Lai;J. Biomater. Sci. Polym. Ed.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart molecules in ophthalmology: Hydrogels as responsive systems for ophthalmic applications;Smart Molecules;2024-03

2. Pharmacological Potential of Sulindac and Its Active Metabolite: A Comprehensive Review;Current Drug Therapy;2023-10-24

3. Recent Advances in Hydrogels for the Diagnosis and Treatment of Dry Eye Disease;Gels;2022-12-11